Psychologists in Weaverville, NC Accepting Medicare
4 Psychologists found. Showing 1 - 4
 John Reilly Iii, MA Psychologist Medicare: Not Enrolled in Medicare Practice Location: 31 Kennedy Road Anx, Weaverville, NC 28787 Phone: 828-775-5814 |
 Dr. Carlyn Marie Daubs, LPA Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 10 Hawtree Ct, Weaverville, NC 28787 Phone: 828-606-0496 Fax: 888-851-7930 |
Dr. Charles John Vanderkolk, PH.D. Psychologist Medicare: Not Enrolled in Medicare Practice Location: 2 Roberts St, Weaverville, NC 28787 Phone: 828-484-9767 Fax: 828-484-9614 |
Dr. Jay Ian Fine, PSY.D. Psychologist - Clinical Medicare: Medicare Enrolled Practice Location: 392 Dula Springs Road, Weaverville, NC 28787 Phone: 828-645-7738 Fax: 828-254-0358 |
News Archive
New research identifies stem cells that generate three critical classes of nerve cells
New research, published in the journal Development, by Dr. Anthony-Samuel LaMantia, professor of Pharmacology & Physiology and director of the newly formed GW Institute for Neuroscience, and his colleagues have identified the stem cells that generate three critical classes of nerve cells - olfactory receptors, vomeronasal and gonadotropin releasing hormone neurons - that are responsible for enabling animals and humans, to eat, interact socially and reproduce.
Study captures interactions of HIV-infected immune cells in living animal
By watching brightly glowing HIV-infected immune cells move within mice, researchers at the Icahn School of Medicine at Mount Sinai have shown how infected immune cells latch onto an uninfected sister cell to directly transmit newly minted viral particles.
Mathematical model predicts COVID-19 resurgence if physical distancing measures are relaxed
If physical distancing measures in Ontario are relaxed too much or too quickly, the province could see hospitals overwhelmed with COVID-19 patients as well as exponential growth in deaths, concludes new research involving a University of Guelph infectious disease modeller.
Chelsea completes successful NORTHERA pre-NDA assessment with FDA
Chelsea Therapeutics International, Ltd. announced it has completed a pre-NDA assessment with the U.S. Food and Drug Administration (FDA) and intends to accelerate its new drug application (NDA) for NORTHERA™(droxidopa) for the treatment of symptomatic, neurogenic orthostatic hypotension (NOH), a chronic and potentially debilitating drop in blood pressure upon standing commonly associated Parkinson's disease, multiple system atrophy and pure autonomic failure.
› Verified 6 days ago
Counselors
Pharmacists
Clinical Social Workers
Dentists
Occupational Therapists
Psychologists